Who
Justin J. McAnear
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Alamar Biosciences; Chief Financial Officer, 10x Genomics.
In numbers
- Trades disclosed
- 228
- Buys
- 1
- Sells
- 38
- Bought
- $6,397
- Sold
- $32.4M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 16 Sep 2019
- Last trade
- 20 Apr 2026
- Last filed
- 20 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar BiosciencesLife-science tools | SEC FORM 4 Code A | —37,220 at $0.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code J | —570,719 at $0.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code J | —570,719 at $0.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code J | —570,719 at $0.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code J | —570,719 at $0.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar BiosciencesLife-science tools | SEC FORM 4 Code A | —37,220 at $0.00 | filing |
| 16 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code A | —163,358 at $0.00 | filing |
| 16 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code A | —163,358 at $0.00 | filing |
| 22 Aug 2024filed 26 Aug 2024 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $67K2,961 at $22.53 | filing |
| 22 May 2024filed 23 May 2024 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $71K2,936 at $24.30 | filing |
| 21 Mar 2024filed 25 Mar 2024 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Code A | —53,312 at $0.00 | filing |
| 22 Feb 2024filed 26 Feb 2024 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $86K1,865 at $46.34 | filing |
| 22 Nov 2023filed 27 Nov 2023 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $73K1,679 at $43.34 | filing |
| 22 Aug 2023filed 24 Aug 2023 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $77K1,678 at $45.78 | filing |
| 23 May 2023filed 25 May 2023 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $11K194 at $55.07 | filing |
| 23 May 2023filed 25 May 2023 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $26K465 at $55.06 | filing |
| 23 May 2023filed 25 May 2023 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $24K441 at $55.06 | filing |
| 23 May 2023filed 25 May 2023 | TXG 10x GenomicsLife-science tools | SEC FORM 4 Sold | $31K565 at $55.06 | filing |
| 21 Mar 2023filed 23 Mar 2023 | TXG 10x Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —25,991 at $0.00 | filing |
| 21 Mar 2023filed 23 Mar 2023 | TXG 10x Genomicsoption or derivative · Life-science tools | SEC FORM 4 Code A | —12,996 at $0.00 | filing |
News
10x Genomics and Fred Hutch partner on cancer technologiesTXG · pharmaceutical-business-review.com · 8 Oct 202610x Genomics (NASDAQ:TXG) Sets New 12-Month High – Here's WhyTXG · dailypolitical.com · 7 Oct 2026
0 headlines in the last 90 days name Justin J. McAnear; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.